As malaria continues to affect millions, new science offers hope. Our new report shows how genetically modified mosquitoes can move from research to responsible use, helping countries prepare for equitable, evidence-based deployment. More from @mggalvin.bsky.social: www.euronews.com/health/2025/...

🔈NGO & Communities Delegations Celebrate Unitaid’s Success in Accelerating Affordable Access to Long-Acting Lenacapavir for PrEP at a price of US$40 per person per year.

See statement:

unitaidngodelegation.org/2025/09/24/u...

@unitaid.bsky.social
@unitaidcommunities.bsky.social
CHAI
WITS RHI

@unitaid.bsky.social @unitaidcommunities.bsky.social

@unitaid.bsky.social @unitaidcommunities.bsky.social

🔈Unitaid NGO & Communities Delegations Celebrate Unitaid’s Success in Accelerating Affordable Access to Long-Acting Lenacapavir for PrEP at a price of US$40 per person per year - just two years after first approvals.

unitaidngodelegation.org/2025/09/24/u...

Register to join our co-ed Florence Anam alongside @unitaid.bsky.social and @kelinkenya.bsky.social leaders on tomorrow's webinar focusing on Community-Driven Regional Manufacturing for HIV Response.

Date: 15 July 2025
Time: 2-3:30
Register here: us06web.zoom.us/webinar/regi...

🔊Reminder to sign up below for our upcoming webinar with
@unitaidcommunities.bsky.social @oneillinstitute.bsky.social

'The Road to Long-Acting Antiretroviral Therapy'

Thursday 17 April
3-4:30pm SAST & CET

💻 georgetown.zoom.us/webinar/regi...